Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease Aged 6 to <12 Years: 2-Year Data from the Phase 2 Solace-Kids Study

Matthew M. Heeney, David C Rees, Slimane Allali, Isaac Odame, Rodolfo D Cançado, Adlette Inati, Elena Cela, Deborah Keefe, Evgeniya Reshetnyak, Velusamy Shanmuganathan Muthusamy, Lidiya Bebrevska, Michele L Nassin, Julie Kanter

Blood (2024) 144 (Supplement 1): 180.

https://doi.org/10.1182/blood-2024-207207

Published: 2024

Journal Articles

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries

Wasil Jastaniah, Regina Hartfield, John James, Biba Tinga, Elvie Ingoli, Mariane de Montalembert, Fernando F. Costa, Alan Randall Anderson, Joachim B. Kunz, Isaac Odame, Belinda Lartey, Baba P.D. Inusa

Blood (2023) 142 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2023-177655

Published: 2023

Journal Articles

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Perspectives of Physicians in Gulf Cooperation Council Countries on Sickle Cell Disease

Wasil Jastaniah, Mariane de Montalembert, Fernando F. Costa, Alan Randall Anderson, Joachim B. Kunz, Isaac Odame, Belinda Lartey, Baba P.D. Inusa

Blood (2023) 142 (Supplement 1): 5309.

https://doi.org/10.1182/blood-2023-177685

Published: 2023

Journal Articles

HU for SCA in Africa: associated malaria benefit

Isaac Odame

Blood (2023) 141 (12): 1370–1371.

https://doi.org/10.1182/blood.2022018873

Published: 2023

Journal Articles

Barriers and Facilitators to Community Acceptability of Integrating Point-of-Care Testing to Screen for Sickle Cell Disease in Children in Primary Healthcare Settings in Rural Northern Ghana

Samuel T. Chatio, Enyonam Duah, Lucy O. Ababio, Nicola Lister, Olufolake Egbujo, Kwaku Marfo, Raymond Aborigo, Patrick Ansah, Isaac Odame

Blood (2022) 140 (Supplement 1): 5018.

https://doi.org/10.1182/blood-2022-165596

Published: 2022

Journal Articles

A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia

Blood (2022) 139 (17): 2642–2652.

https://doi.org/10.1182/blood.2021013674

Published: 2022

Includes: Supplemental data

Journal Articles

Multispectral Imaging for Microchip Electrophoresis Enables Point-of-Care Newborn Hemoglobin Variant Screening

Ran An, Yuning Huang, Anne Rocheleau, Alireza Avanaki, Priyaleela Thota, Yuncheng Man, Zoe Sekyonda, Catherine Segbefia, Yvonne Adomakoh, Enoch Mensah, Isaac Odame, Umut A. Gurkan

Blood (2021) 138 (Supplement 1): 2956.

https://doi.org/10.1182/blood-2021-151731

Published: 2021

Journal Articles

Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD)

Matthew M. Heeney, David C. Rees, Mariane De Montalembert, Isaac Odame, R. Clark Clark Brown, Yasser Wali, Thu Thuy Nguyen, Du Lam, Nadege Pfender, Julie Kanter

Blood (2021) 138 (Supplement 1): 12.

https://doi.org/10.1182/blood-2021-144730

Published: 2021

Journal Articles

Study Design and Initial Baseline Characteristics in Solace-Kids: Crizanlizumab in Pediatric Patients with Sickle Cell Disease

Matthew M. Heeney, MD, David C. Rees, MD, Mariane de Montalembert, MD PhD, Isaac Odame, MD, R. Clark Brown, MD PhD, Yasser Wali, MD, Thu Thuy Nguyen, Du Lam, MD, Raquel Merino Herranz, Julie Kanter, MD

Blood (2020) 136 (Supplement 1): 22–24.

https://doi.org/10.1182/blood-2020-137081

Published: 2020

Journal Articles

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Blood (2019) 134 (Supplement_1): 615.

https://doi.org/10.1182/blood-2019-123355

Published: 2019

Journal Articles

Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013

Ewurabena Simpson, MD FRCPC, MPH, Robert J Klaassen, MD FRCPC, Pranesh Chakraborty, MD FRCPC, FCCMG, Beth Potter, PhD, Melanie Ann Kirby-Allen, MBBS, Isaac Odame, Suzan Williams, MD, Uma Athale, MD MBBS, MSc, Lawrence Jardine, MD BA, FRCPC, Paul J. Gibson, MD, Mariana Silva, MD FRCPC, Manuela Merelles-Pulcini, Brooke Bowerman, BSc, William Petrcich, MSc, Eric I Benchimol, MD PhD FRCPC

Blood (2018) 132 (Supplement 1): 4698.

https://doi.org/10.1182/blood-2018-99-110468

Published: 2018

Journal Articles

Hydroxyurea for SCA in Africa: no malaria harm

Isaac Odame

Blood (2017) 130 (24): 2575–2576.

https://doi.org/10.1182/blood-2017-10-812974

Published: 2017

Journal Articles

Serum Ferritin Underestimates Liver Iron Concentration in Patients with Homozygous Alpha-0 Thalassemia

Ali Amid, MD, Shiyi Chen, Uma Athale, Karen Charpentier, Manuela Merelles-Pulcini, Isaac Odame, Melanie Ann Kirby-Allen

Blood (2017) 130 (Supplement 1): 3504.

https://doi.org/10.1182/blood.V130.Suppl_1.3504.3504

Published: 2017

Journal Articles

Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial

John C Wood, MD PhD, Tim St Pierre, PhD, Banu Aygun, MD, Nicole Mortier, PA-C, William H Schultz, MHS PA, Connie M. Piccone, MD, Jane Hankins, MD MS, Zora R. Rogers, MD, William Owen, MD, Isaac Odame, MBChB, FRCPath, FRCPC, Sharada A. Sarnaik, MD, Lee Hilliard, MD, Alan R. Cohen, MD, Russell E. Ware, MD PhD

Blood (2016) 128 (22): 1274.

https://doi.org/10.1182/blood.V128.22.1274.1274

Published: 2016

Journal Articles

Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults

Brooke Allemang, MSW, RSW, Kate Allan, MSW, Colleen Johnson, BScN, MN/NP, Melina Cheong, BScN, MN/NP, Patrina Cheung, BSc, Isaac Odame, MBChB, FRCPath, FRCPC, Richard Ward, MSc, MRCP, FRCPath, Suzan Williams, MD MSc, FRCPC, Kevin H.M. Kuo, MD MSc, FRCPC

Blood (2016) 128 (22): 317.

https://doi.org/10.1182/blood.V128.22.317.317

Published: 2016

Journal Articles

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis

Ali Amid, Shiyi Chen, William Brien, Melanie Kirby-Allen, Isaac Odame

Blood (2016) 127 (9): 1208–1211.

https://doi.org/10.1182/blood-2015-10-673889

Published: 2016

Includes: Supplemental data

Journal Articles

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Russell E. Ware, MD PhD, Barry R Davis, MD PhD, William H Schultz, MHS PA, Clark Brown, MD PhD, Banu Aygun, MD, Sharada A. Sarnaik, MD, Isaac Odame, MD, Beng Fuh, MD, Alex George, MD, PhD, William Owen, MD, Lori Luchtman-Jones, MD, Zora R. Rogers, MD, Lee Hilliard, MD, Cynthia Gauger, MD, Connie M. Piccone, MD, Margaret T. Lee, MD, Janet Kwiatkowski, MD, Sherron Jackson, MD, Scott T. Miller, MD, Carla W Roberts, MD, Matthew M. Heeney, MD FRCP(C), Theodosia A. Kalfa, MD PhD, Stephen C Nelson, MD, Hamayun Imran, MD, Kerri A Nottage, MD MPH, Ofelia A. Alvarez, MD, Melissa Rhodes, MD, Alexis A. Thompson, MD, Jennifer Rothman, MD, Kathleen J. Helton, MD, Donna Roberts, MD, Jamie Coleman, MD, Melanie J Bonner, PhD, Abdullah Kutlar, MD, Niren Patel, MD, John C Wood, MD PhD, Linda Piller, MD, Peng Wei, PhD, Judy Luden, CCRP, Nicole A. Mortier, MHS, PA-C, Susan Stuber, MA, Naomi L.C. Luban, MD, Alan R. Cohen, MD, Sara L Pressel, MS, Robert J. Adams, MD MS

Blood (2015) 126 (23): 3.

https://doi.org/10.1182/blood.V126.23.3.3

Published: 2015

Journal Articles

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Timothy L. McCavit, MD, MS, Lakshmanan Krishnamurti, MD, Lewis L. Hsu, MD, PhD, Charles T. Quinn, MD, MS, Isaac Odame, MD, Ofelia A. Alvarez, MD, Catherine Driscoll, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Ted Wun, MD, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 2206.

https://doi.org/10.1182/blood.V122.21.2206.2206

Published: 2013

Journal Articles

Liver Iron Concentration By MRI In Chronically Transfused Children With Sickle Cell Anemia In The Twitch Trial

John C. Wood, MD, PhD, Zora R. Rogers, MD, Isaac Odame, MD, Janet Kwiatkowski, MD, Margaret Lee, MD, William C. Owen, MD, Alan Cohen, MD, Timothy St. Pierre, PhD, Barry R Davis, MD, PhD, Crystal Parker, MS, William Herbert Schultz, PA-C, Russell E. Ware, MD, PhD

Blood (2013) 122 (21): 780.

https://doi.org/10.1182/blood.V122.21.780.780

Published: 2013

Journal Articles

Outcome and Clinical Characteristics of Clonal and Malignant Myeloid Transformation in Inherited Bone Marrow Failure Syndromes

Blood (2012) 120 (21): 1266.

https://doi.org/10.1182/blood.V120.21.1266.1266

Published: 2012

NARROW

Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease Aged 6 to <12 Years: 2-Year Data from the Phase 2 Solace-Kids Study

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries

Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Perspectives of Physicians in Gulf Cooperation Council Countries on Sickle Cell Disease

HU for SCA in Africa: associated malaria benefit

Barriers and Facilitators to Community Acceptability of Integrating Point-of-Care Testing to Screen for Sickle Cell Disease in Children in Primary Healthcare Settings in Rural Northern Ghana

A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia

Multispectral Imaging for Microchip Electrophoresis Enables Point-of-Care Newborn Hemoglobin Variant Screening

Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD)

Study Design and Initial Baseline Characteristics in Solace-Kids: Crizanlizumab in Pediatric Patients with Sickle Cell Disease

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013

Hydroxyurea for SCA in Africa: no malaria harm

Serum Ferritin Underestimates Liver Iron Concentration in Patients with Homozygous Alpha-0 Thalassemia

Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial

Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Liver Iron Concentration By MRI In Chronically Transfused Children With Sickle Cell Anemia In The Twitch Trial

Outcome and Clinical Characteristics of Clonal and Malignant Myeloid Transformation in Inherited Bone Marrow Failure Syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only